Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
What You Missed On Wall Street This Morning » 12:02
08/16/22
08/16
12:02
08/16/22
12:02
DNA

Ginkgo Bioworks

$3.75 /

+0.265 (+7.60%)

, ZM

Zoom Video

$108.45 /

-4.66 (-4.12%)

, SNOW

Snowflake

$162.61 /

-7.7 (-4.52%)

, BBBY

Bed Bath & Beyond

$26.13 /

+10.135 (+63.36%)

, WMT

Walmart

$140.64 /

+8.06 (+6.08%)

, HD

Home Depot

$330.11 /

+15.84 (+5.04%)

, WWE

WWE

$73.59 /

+1.56 (+2.17%)

, ZIP

ZipRecruiter

$19.48 /

-1.48 (-7.06%)

, PYPL

PayPal

$102.28 /

+0.77 (+0.76%)

, V

Visa

$214.99 /

-1.38 (-0.64%)

, MA

MasterCard

$356.90 /

-2.99 (-0.83%)

, MATX

Matson

$85.23 /

-0.63 (-0.73%)

, AMZN

Amazon.com

$144.03 /

+0.94 (+0.66%)

, AZN

AstraZeneca

$66.66 /

-0.15 (-0.22%)

, GSK

GSK plc

$35.07 /

+0.14 (+0.40%)

, MMM

3M

$150.40 /

-1.06 (-0.70%)

, BMWYY

BMW

$26.51 /

-0.59 (-2.18%)

, TCEHY

Tencent

$38.31 /

-0.125 (-0.33%)

, BLND

Blend Labs

$3.37 /

+0.61 (+22.14%)

, IONQ

IonQ

$8.06 /

+1.67 (+26.13%)

, GLBE

Global-e Online

$35.10 /

+7.75 (+28.34%)

, SMFR

Sema4 Holdings

$1.71 /

-0.69 (-28.75%)

, ALBO

Albireo Pharma

$18.97 /

-5.91 (-23.75%)

, POWW

AMMO

$4.47 /

-0.925 (-17.15%)

, BE

Bloom Energy

$27.49 /

-2.865 (-9.44%)

, COMP

Compass

$4.14 /

-0.53 (-11.35%)

, ECC

Eagle Point Credit

$12.04 /

+0.445 (+3.84%)

, LITE

Lumentum

$90.86 /

-5.42 (-5.63%)

, GENI

Genius Sports

$4.61 /

+0.065 (+1.43%)

, PINC

Premier

$38.36 /

-0.15 (-0.39%)

Get caught up quickly on…

ShowHide Related Items >><<
ZM Zoom Video
$108.45 /

-4.66 (-4.12%)

ZIP ZipRecruiter
$19.48 /

-1.48 (-7.06%)

WWE WWE
$73.59 /

+1.56 (+2.17%)

WMT Walmart
$140.64 /

+8.06 (+6.08%)

V Visa
$214.99 /

-1.38 (-0.64%)

TCEHY Tencent
$38.31 /

-0.125 (-0.33%)

SNOW Snowflake
$162.61 /

-7.7 (-4.52%)

SMFR Sema4 Holdings
$1.71 /

-0.69 (-28.75%)

PYPL PayPal
$102.28 /

+0.77 (+0.76%)

POWW AMMO
$4.47 /

-0.925 (-17.15%)

PINC Premier
$38.36 /

-0.15 (-0.39%)

MMM 3M
$150.40 /

-1.06 (-0.70%)

MATX Matson
$85.23 /

-0.63 (-0.73%)

MA MasterCard
$356.90 /

-2.99 (-0.83%)

LITE Lumentum
$90.86 /

-5.42 (-5.63%)

IONQ IonQ
$8.06 /

+1.67 (+26.13%)

HD Home Depot
$330.11 /

+15.84 (+5.04%)

GSK GSK plc
$35.07 /

+0.14 (+0.40%)

GLBE Global-e Online
$35.10 /

+7.75 (+28.34%)

GENI Genius Sports
$4.61 /

+0.065 (+1.43%)

DNA Ginkgo Bioworks
$3.75 /

+0.265 (+7.60%)

COMP Compass
$4.14 /

-0.53 (-11.35%)

BMWYY BMW
$26.51 /

-0.59 (-2.18%)

BLND Blend Labs
$3.37 /

+0.61 (+22.14%)

BE Bloom Energy
$27.49 /

-2.865 (-9.44%)

BBBY Bed Bath & Beyond
$26.13 /

+10.135 (+63.36%)

AZN AstraZeneca
$66.66 /

-0.15 (-0.22%)

AMZN Amazon.com
$144.03 /

+0.94 (+0.66%)

ALBO Albireo Pharma
$18.97 /

-5.91 (-23.75%)

DNA Ginkgo Bioworks
$3.75 /

+0.265 (+7.60%)

08:19 Today BTIG
Ginkgo Bioworks price target raised to $6 from $5 at BTIG
06:56 Today Raymond James
Ginkgo Bioworks price target raised to $14.50 from $11.50 at Raymond James
07/26/22 William Blair
Zymergen buyout deal 'best case scenario,' says William Blair
07/26/22 JPMorgan
Zymergen upgraded to Neutral from Underweight at JPMorgan
ZM Zoom Video
$108.45 /

-4.66 (-4.12%)

05:10 Today Citi
Zoom Video downgraded to Sell from Neutral at Citi
08/04/22 MKM Partners
Zoom Video initiated with a Buy at MKM Partners
08/03/22 Craig-Hallum
RingCentral price target lowered to $110 from $175 at Craig-Hallum
07/19/22 Bernstein
Zoom Video initiated with a Market Perform at Bernstein
SNOW Snowflake
$162.61 /

-7.7 (-4.52%)

08:45 Today Barclays
Snowflake price target raised to $210 from $158 at Barclays
06:38 Today Citi
Citi opens negative Catalyst Watch on Snowflake ahead of earnings
06:02 Today UBS
Snowflake downgraded to Neutral at UBS following field checks
05:45 Today UBS
Snowflake downgraded to Neutral from Buy at UBS
BBBY Bed Bath & Beyond
$26.13 /

+10.135 (+63.36%)

09:00 Today B. Riley
B. Riley downgrades 'meme stock' Bed Bath & Beyond to Sell
05:48 Today B. Riley
Bed Bath & Beyond downgraded to Sell from Neutral at B. Riley
08/09/22 Baird
Baird downgrades Bed Bath & Beyond to sell after 86% two-day rally
08/09/22 Baird
Bed Bath & Beyond downgraded to Underperform from Neutral at Baird
WMT Walmart
$140.64 /

+8.06 (+6.08%)

11:38 Today Wells Fargo
Walmart price target raised to $155 from $130 at Wells Fargo
07/29/22 BofA
Amazon price target bumped to $170 at BofA after 'mostly positive' quarter
07/28/22 DA Davidson
Best Buy price target lowered to $88 from $110 at DA Davidson
07/28/22 Wells Fargo
Best Buy price target lowered to $70 from $82 at Wells Fargo
HD Home Depot
$330.11 /

+15.84 (+5.04%)

11:38 Today Wells Fargo
Home Depot shares 'can work nicely from here,' says Wells Fargo
08/11/22 Citi
Lowe's downgraded to Neutral from Buy at Citi
08/09/22 JPMorgan
Home Depot price target lowered to $311 from $335 at JPMorgan
06/22/22 MKM Partners
Home Depot initiated with a Neutral at MKM Partners
WWE WWE
$73.59 /

+1.56 (+2.17%)

07/26/22 Benchmark
WWE price target raised to $80 from $71 at Benchmark
07/25/22 Loop Capital
Loop Capital upgrades WWE to Buy on rising likelihood of company sale
07/25/22 MKM Partners
WWE price target raised to $79 from $70 at MKM Partners
07/25/22 Loop Capital
WWE upgraded to Buy from Hold at Loop Capital
ZIP ZipRecruiter
$19.48 /

-1.48 (-7.06%)

08:41 Today Barclays
ZipRecruiter price target lowered to $25 from $30 at Barclays
06:29 Today Raymond James
ZipRecruiter price target lowered to $30 from $40 at Raymond James
06/29/22 JPMorgan
ZipRecruiter price target lowered to $19 from $22 at JPMorgan
06/09/22 Goldman Sachs
ZipRecruiter price target lowered to $26 from $30 at Goldman Sachs
PYPL PayPal
$102.28 /

+0.77 (+0.76%)

05:43 Today Daiwa
PayPal upgraded to Outperform from Neutral at Daiwa
08/08/22 Mizuho
PayPal price target lowered to $118 from $120 at Mizuho
08/04/22 BMO Capital
PayPal price target raised to $124 from $114 at BMO Capital
08/04/22 Barclays
PayPal price target raised to $131 from $125 at Barclays
V Visa
$214.99 /

-1.38 (-0.64%)

05:44 Today Daiwa
Visa downgraded to Neutral from Outperform at Daiwa
08/03/22 Truist
PayPal price target raised to $108 from $80 at Truist
08/01/22 BMO Capital
MasterCard price target raised to $422 from $402 at BMO Capital
07/29/22 Mizuho
Visa price target raised to $220 from $215 at Mizuho
MA MasterCard
$356.90 /

-2.99 (-0.83%)

05:47 Today Daiwa
MasterCard downgraded to Neutral from Outperform at Daiwa
05:44 Today Daiwa
MasterCard downgraded to Neutral from Outperform at Daiwa
MATX Matson
$85.23 /

-0.63 (-0.73%)

07:07 Today Wolfe Research
Wolfe starts Matson at Underperform, sees 'peak EPS' in 2022
06:44 Today Wolfe Research
Matson initiated with an Underperform at Wolfe Research
08/02/22 Stifel
Matson downgraded to Hold at Stifel with freight rates starting to roll over
08/01/22 Stifel
Matson downgraded to Hold from Buy at Stifel
AMZN Amazon.com
$144.03 /

+0.94 (+0.66%)

08/15/22 Jefferies
1Life Healthcare downgraded to Hold from Buy at Jefferies
08/11/22 Craig-Hallum
Kornit Digital price target raised to $32 from $26 at Craig-Hallum
08/10/22 Macquarie
Macquarie started Coupang at Outperform with $26 target yesterday
08/10/22 Oppenheimer
Trade Desk price target raised to $78 from $60 at Oppenheimer
AZN AstraZeneca
$66.66 /

-0.15 (-0.22%)

08/05/22 Morgan Stanley
AstraZeneca price target raised to 12,000 GBp from 11,500 GBp at Morgan Stanley
08/04/22 Barclays
AstraZeneca price target lowered to 12,000 GBp from 12,500 GBp at Barclays
08/01/22 JPMorgan
AstraZeneca price target raised to 12,500 GBp from 12,000 GBp at JPMorgan
08/01/22 Deutsche Bank
AstraZeneca price target raised to 12,000 GBp from 11,500 GBp at Deutsche Bank
GSK GSK plc
$35.07 /

+0.14 (+0.40%)

06:11 Today Oppenheimer
Ideaya Biosciences price target lowered to $20 from $25 at Oppenheimer
08/15/22 RBC Capital
Haleon initiated with a Sector Perform at RBC Capital
08/15/22 Stifel
Ideaya Biosciences downgraded to Hold at Stifel after GSK waives IDE397 opt-in
08/12/22 JPMorgan
Sanofi may not be liable for any Zantac litigation damages, says JPMorgan
MMM 3M
$150.40 /

-1.06 (-0.70%)

07/27/22 Deutsche Bank
3M price target raised to $148 from $146 at Deutsche Bank
07/27/22 Wells Fargo
3M price target raised to $144 from $137 at Wells Fargo
07/27/22 Mizuho
3M price target raised to $140 from $130 at Mizuho
07/27/22 Barclays
3M price target lowered to $137 from $143 at Barclays
BMWYY BMW
$26.51 /

-0.59 (-2.18%)

08/05/22 Societe Generale
BMW price target lowered to EUR 110 from EUR 115 at Societe Generale
08/05/22 Barclays
BMW price target lowered to EUR 95 from EUR 100 at Barclays
08/05/22 RBC Capital
BMW price target raised to EUR 107 from EUR 105 at RBC Capital
05/18/22 Exane BNP Paribas
Tesla gets price target cut after losing Exane's 'EV World Cup'
TCEHY Tencent
$38.31 /

-0.125 (-0.33%)

08/01/22 Goldman Sachs
Bilibili received one China game approval for August, says Goldman Sachs
07/11/22 Goldman Sachs
Tencent downgraded to Buy from Conviction Buy at Goldman Sachs
07/05/22 Macquarie
China online gaming re-ratings 'about to begin,' says Macquarie
06/28/22 Investec
Tencent downgraded to Sell from Hold at Investec
BLND Blend Labs
$3.37 /

+0.61 (+22.14%)

07/24/22 Keefe Bruyette
Blend Labs downgraded to Underperform from Market Perform at Keefe Bruyette
07/18/22 Piper Sandler
Blend Labs price target lowered to $2.50 from $3.50 at Piper Sandler
07/07/22 KeyBanc
KeyBanc downgrades Blend Labs to Sector Weight on challenging market conditions
07/07/22 KeyBanc
Blend Labs downgraded to Sector Weight from Overweight at KeyBanc
IONQ IonQ
$8.06 /

+1.67 (+26.13%)

07/15/22 Goldman Sachs
IonQ price target lowered to $8 from $10 at Goldman Sachs
06/08/22 Needham
Needham starts IonQ at Buy as market leader in ion trap quantum computers
06/07/22 Needham
IonQ initiated with a Buy at Needham
05/20/22
IonQ participates in a conference call with Benchmark
GLBE Global-e Online
$35.10 /

+7.75 (+28.34%)

07/18/22 Piper Sandler
Global-e Online price target lowered to $28 from $30 at Piper Sandler
07/14/22 Goldman Sachs
Global-e Online price target raised to $31 from $28 at Goldman Sachs
05/17/22 Jefferies
Global-e Online price target lowered to $31 from $70 at Jefferies
05/17/22 Needham
Global-e Online price target lowered to $25 from $75 at Needham
SMFR Sema4 Holdings
$1.71 /

-0.69 (-28.75%)

07:43 Today Jefferies
Jefferies downgrades Sema4 to Hold, halves price target to $2
05:50 Today Jefferies
Sema4 Holdings downgraded to Hold from Buy at Jefferies
06/02/22 Goldman Sachs
Sema4 Holdings reinstated with a Buy at Goldman Sachs
05/16/22 Cowen
Sema4 Holdings price target lowered to $5 from $13 at Cowen
ALBO Albireo Pharma
$18.97 /

-5.91 (-23.75%)

08:09 Today Wedbush
Albireo Pharma price target lowered to $61 from $72 at Wedbush
07:34 Today H.C. Wainwright
Albireo Pharma price target lowered to $54 from $80 at H.C. Wainwright
07:08 Today Baird
Albireo Pharma price target lowered to $40 from $66 at Baird
05/17/22 Baird
Albireo Pharma price target lowered to $66 from $72 at Baird
POWW AMMO
$4.47 /

-0.925 (-17.15%)

08:54 Today Lake Street
AMMO price target lowered to $9 from $12 at Lake Street
06/30/22 EF Hutton
AMMO shares should be bought 'aggressively,' says EF Hutton
08/17/21 Lake Street
AMMO price target raised to $12 at Lake Street after beat and raise report
BE Bloom Energy
$27.49 /

-2.865 (-9.44%)

08/11/22 BMO Capital
Bloom Energy price target raised to $29 from $20 at BMO Capital
08/11/22 Truist
Bloom Energy price target raised to $31 from $19 at Truist
08/10/22 Raymond James
Bloom Energy price target raised to $29 from $23 at Raymond James
08/10/22 Susquehanna
Bloom Energy price target raised to $30 from $28 at Susquehanna
COMP Compass
$4.14 /

-0.53 (-11.35%)

08:47 Today Barclays
Compass price target lowered to $5 from $7 at Barclays
07/21/22 Morgan Stanley
Compass downgraded to Equal Weight from Overweight at Morgan Stanley
05/16/22 Oppenheimer
Compass price target lowered to $9 from $14 at Oppenheimer
04/22/22 Zelman
Compass initiated with a Hold at Zelman
ECC Eagle Point Credit
$12.04 /

+0.445 (+3.84%)

09/23/21 B. Riley
Eagle Point Credit resumed with a Buy at B. Riley
LITE Lumentum
$90.86 /

-5.42 (-5.63%)

08/08/22 Craig-Hallum
Lumentum price target raised to $125 from $115 at Craig-Hallum
07/25/22 Barclays
Lumentum price target lowered to $95 from $100 at Barclays
07/14/22 JPMorgan
Lumentum price target lowered to $100 from $115 at JPMorgan
06/06/22 Jefferies
Service Provider capex should remain resilient, says Jefferies
GENI Genius Sports
$4.61 /

+0.065 (+1.43%)

07/07/22 Citi
Genius Sports price target lowered to $6 from $8 at Citi
06/28/22 B. Riley
Genius Sports price target lowered to $5.50 from $9 at B. Riley
06/09/22 Citi
Genius Sports price target lowered to $8 from $12 at Citi
05/25/22 B. Riley
Genius Sports price target lowered to $9 from $13 at B. Riley
PINC Premier
$38.36 /

-0.15 (-0.39%)

05/04/22 Canaccord
Premier price target lowered to $44 from $47 at Canaccord
05/04/22 Piper Sandler
Premier upgraded to Overweight from Neutral at Piper Sandler
04/13/22 Guggenheim
Premier initiated with a Neutral at Guggenheim
03/31/22 Credit Suisse
Premier assumed with an Underperform at Credit Suisse
ZM Zoom Video
$108.45 /

-4.66 (-4.12%)

ZIP ZipRecruiter
$19.48 /

-1.48 (-7.06%)

WWE WWE
$73.59 /

+1.56 (+2.17%)

WMT Walmart
$140.64 /

+8.06 (+6.08%)

V Visa
$214.99 /

-1.38 (-0.64%)

SNOW Snowflake
$162.61 /

-7.7 (-4.52%)

SMFR Sema4 Holdings
$1.71 /

-0.69 (-28.75%)

PYPL PayPal
$102.28 /

+0.77 (+0.76%)

POWW AMMO
$4.47 /

-0.925 (-17.15%)

PINC Premier
$38.36 /

-0.15 (-0.39%)

MMM 3M
$150.40 /

-1.06 (-0.70%)

MATX Matson
$85.23 /

-0.63 (-0.73%)

MA MasterCard
$356.90 /

-2.99 (-0.83%)

LITE Lumentum
$90.86 /

-5.42 (-5.63%)

IONQ IonQ
$8.06 /

+1.67 (+26.13%)

HD Home Depot
$330.11 /

+15.84 (+5.04%)

GSK GSK plc
$35.07 /

+0.14 (+0.40%)

GLBE Global-e Online
$35.10 /

+7.75 (+28.34%)

GENI Genius Sports
$4.61 /

+0.065 (+1.43%)

ECC Eagle Point Credit
$12.04 /

+0.445 (+3.84%)

DNA Ginkgo Bioworks
$3.75 /

+0.265 (+7.60%)

COMP Compass
$4.14 /

-0.53 (-11.35%)

BLND Blend Labs
$3.37 /

+0.61 (+22.14%)

BE Bloom Energy
$27.49 /

-2.865 (-9.44%)

BBBY Bed Bath & Beyond
$26.13 /

+10.135 (+63.36%)

AZN AstraZeneca
$66.66 /

-0.15 (-0.22%)

AMZN Amazon.com
$144.03 /

+0.94 (+0.66%)

ALBO Albireo Pharma
$18.97 /

-5.91 (-23.75%)

  • 17
    Aug
  • 20
    Nov
  • 10
    Sep
ZM Zoom Video
$108.45 /

-4.66 (-4.12%)

ZIP ZipRecruiter
$19.48 /

-1.48 (-7.06%)

WWE WWE
$73.59 /

+1.56 (+2.17%)

WMT Walmart
$140.64 /

+8.06 (+6.08%)

V Visa
$214.99 /

-1.38 (-0.64%)

TCEHY Tencent
$38.31 /

-0.125 (-0.33%)

SNOW Snowflake
$162.61 /

-7.7 (-4.52%)

PYPL PayPal
$102.28 /

+0.77 (+0.76%)

PINC Premier
$38.36 /

-0.15 (-0.39%)

MMM 3M
$150.40 /

-1.06 (-0.70%)

MA MasterCard
$356.90 /

-2.99 (-0.83%)

IONQ IonQ
$8.06 /

+1.67 (+26.13%)

HD Home Depot
$330.11 /

+15.84 (+5.04%)

GSK GSK plc
$35.07 /

+0.14 (+0.40%)

GENI Genius Sports
$4.61 /

+0.065 (+1.43%)

BMWYY BMW
$26.51 /

-0.59 (-2.18%)

BE Bloom Energy
$27.49 /

-2.865 (-9.44%)

BBBY Bed Bath & Beyond
$26.13 /

+10.135 (+63.36%)

AZN AstraZeneca
$66.66 /

-0.15 (-0.22%)

AMZN Amazon.com
$144.03 /

+0.94 (+0.66%)

ZM Zoom Video
$108.45 /

-4.66 (-4.12%)

ZIP ZipRecruiter
$19.48 /

-1.48 (-7.06%)

WWE WWE
$73.59 /

+1.56 (+2.17%)

WMT Walmart
$140.64 /

+8.06 (+6.08%)

V Visa
$214.99 /

-1.38 (-0.64%)

TCEHY Tencent
$38.31 /

-0.125 (-0.33%)

SNOW Snowflake
$162.61 /

-7.7 (-4.52%)

PYPL PayPal
$102.28 /

+0.77 (+0.76%)

POWW AMMO
$4.47 /

-0.925 (-17.15%)

PINC Premier
$38.36 /

-0.15 (-0.39%)

MMM 3M
$150.40 /

-1.06 (-0.70%)

MA MasterCard
$356.90 /

-2.99 (-0.83%)

IONQ IonQ
$8.06 /

+1.67 (+26.13%)

HD Home Depot
$330.11 /

+15.84 (+5.04%)

GSK GSK plc
$35.07 /

+0.14 (+0.40%)

GLBE Global-e Online
$35.10 /

+7.75 (+28.34%)

GENI Genius Sports
$4.61 /

+0.065 (+1.43%)

DNA Ginkgo Bioworks
$3.75 /

+0.265 (+7.60%)

COMP Compass
$4.14 /

-0.53 (-11.35%)

BMWYY BMW
$26.51 /

-0.59 (-2.18%)

BLND Blend Labs
$3.37 /

+0.61 (+22.14%)

BE Bloom Energy
$27.49 /

-2.865 (-9.44%)

BBBY Bed Bath & Beyond
$26.13 /

+10.135 (+63.36%)

AZN AstraZeneca
$66.66 /

-0.15 (-0.22%)

AMZN Amazon.com
$144.03 /

+0.94 (+0.66%)

ZM Zoom Video
$108.45 /

-4.66 (-4.12%)

ZIP ZipRecruiter
$19.48 /

-1.48 (-7.06%)

WMT Walmart
$140.64 /

+8.06 (+6.08%)

V Visa
$214.99 /

-1.38 (-0.64%)

SNOW Snowflake
$162.61 /

-7.7 (-4.52%)

PYPL PayPal
$102.28 /

+0.77 (+0.76%)

POWW AMMO
$4.47 /

-0.925 (-17.15%)

MMM 3M
$150.40 /

-1.06 (-0.70%)

MATX Matson
$85.23 /

-0.63 (-0.73%)

IONQ IonQ
$8.06 /

+1.67 (+26.13%)

HD Home Depot
$330.11 /

+15.84 (+5.04%)

GSK GSK plc
$35.07 /

+0.14 (+0.40%)

GLBE Global-e Online
$35.10 /

+7.75 (+28.34%)

DNA Ginkgo Bioworks
$3.75 /

+0.265 (+7.60%)

COMP Compass
$4.14 /

-0.53 (-11.35%)

BLND Blend Labs
$3.37 /

+0.61 (+22.14%)

BE Bloom Energy
$27.49 /

-2.865 (-9.44%)

BBBY Bed Bath & Beyond
$26.13 /

+10.135 (+63.36%)

AZN AstraZeneca
$66.66 /

-0.15 (-0.22%)

AMZN Amazon.com
$144.03 /

+0.94 (+0.66%)

COMP Compass
$4.14 /

-0.53 (-11.35%)

Periodicals
AstraZeneca sues former dealmaker for sharing data with GSK, Bloomberg reports » 09:25
08/16/22
08/16
09:25
08/16/22
09:25
AZN

AstraZeneca

$66.81 /

+0.14 (+0.21%)

, GSK

GSK plc

$34.93 /

-1.115 (-3.09%)

AstraZeneca (AZN) sued…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GSK GSK plc
$34.93 /

-1.115 (-3.09%)

AZN AstraZeneca
$66.81 /

+0.14 (+0.21%)

AZN AstraZeneca
$66.81 /

+0.14 (+0.21%)

08/05/22 Morgan Stanley
AstraZeneca price target raised to 12,000 GBp from 11,500 GBp at Morgan Stanley
08/04/22 Barclays
AstraZeneca price target lowered to 12,000 GBp from 12,500 GBp at Barclays
08/01/22 JPMorgan
AstraZeneca price target raised to 12,500 GBp from 12,000 GBp at JPMorgan
08/01/22 Deutsche Bank
AstraZeneca price target raised to 12,000 GBp from 11,500 GBp at Deutsche Bank
GSK GSK plc
$34.93 /

-1.115 (-3.09%)

06:11 Today Oppenheimer
Ideaya Biosciences price target lowered to $20 from $25 at Oppenheimer
08/15/22 RBC Capital
Haleon initiated with a Sector Perform at RBC Capital
08/15/22 Stifel
Ideaya Biosciences downgraded to Hold at Stifel after GSK waives IDE397 opt-in
08/12/22 JPMorgan
Sanofi may not be liable for any Zantac litigation damages, says JPMorgan
GSK GSK plc
$34.93 /

-1.115 (-3.09%)

AZN AstraZeneca
$66.81 /

+0.14 (+0.21%)

GSK GSK plc
$34.93 /

-1.115 (-3.09%)

AZN AstraZeneca
$66.81 /

+0.14 (+0.21%)

GSK GSK plc
$34.93 /

-1.115 (-3.09%)

AZN AstraZeneca
$66.81 /

+0.14 (+0.21%)

GSK GSK plc
$34.93 /

-1.115 (-3.09%)

AZN AstraZeneca
$66.81 /

+0.14 (+0.21%)

Recommendations
DarioHealth price target lowered to $14 from $18 at Cowen » 07:31
08/16/22
08/16
07:31
08/16/22
07:31
DRIO

DarioHealth

$6.71 /

-0.43 (-6.02%)

, SNY

Sanofi

$43.85 /

-0.54 (-1.22%)

Cowen analyst Charles…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$43.85 /

-0.54 (-1.22%)

DRIO DarioHealth
$6.71 /

-0.43 (-6.02%)

DRIO DarioHealth
$6.71 /

-0.43 (-6.02%)

05/16/22 Cowen
DarioHealth price target raised to $18 from $14 at Cowen
05/13/22 Alliance Global Partners
DarioHealth upgraded to Buy from Neutral at Alliance Global Partners
04/18/22 Cowen
DarioHealth price target lowered to $14 from $30 at Cowen
03/02/22 Alliance Global Partners
DarioHealth pact with Sanofi 'potentially game changing,' says Alliance Global
SNY Sanofi
$43.85 /

-0.54 (-1.22%)

08/15/22 Jefferies
Kymera Therapeutics initiated with a Buy at Jefferies
08/12/22 Deutsche Bank
Deutsche Bank raises Sanofi to Hold, calls Zantac 'knee-jerk' reaction overdone
08/12/22 JPMorgan
Sanofi may not be liable for any Zantac litigation damages, says JPMorgan
08/12/22 Deutsche Bank
Sanofi upgraded to Hold from Sell at Deutsche Bank
SNY Sanofi
$43.85 /

-0.54 (-1.22%)

DRIO DarioHealth
$6.71 /

-0.43 (-6.02%)

SNY Sanofi
$43.85 /

-0.54 (-1.22%)

SNY Sanofi
$43.85 /

-0.54 (-1.22%)

Hot Stocks
FDA accepts submission of sNDA for LYNPARZA prednisolone combo for mCRPC » 07:05
08/16/22
08/16
07:05
08/16/22
07:05
MRK

Merck

$90.60 /

-0.39 (-0.43%)

, AZN

AstraZeneca

$66.81 /

+0.14 (+0.21%)

AstraZeneca (AZN) and…

AstraZeneca (AZN) and Merck (MRK) announced that a supplemental New Drug Application, sNDA, for LYNPARZA in combination with abiraterone and prednisone or prednisolone has been accepted and granted priority review by the U.S. Food and Drug Administration for the treatment of adult patients with metastatic castration-resistant prostate cancer, mCRPC. The FDA has set a Prescription Drug User Fee Act or target action, date in the fourth quarter of 2022. Susan Galbraith, executive vice president, oncology R&D, AstraZeneca, said, "There remains a critical unmet need among patients diagnosed with mCRPC, where the prognosis remains poor, and treatment options are limited. Today's news is another step towards bringing forward a new, much-needed treatment option in this setting. If approved, LYNPARZA with abiraterone will become the first combination of a PARP inhibitor and a new hormonal agent for patients with this disease." The sNDA was based on results from the Phase 3 PROpel trial, which were presented at the 2022 American Society of Clinical Oncology Genitourinary Cancers Symposium and later published in NEJM Evidence.

ShowHide Related Items >><<
MRK Merck
$90.60 /

-0.39 (-0.43%)

AZN AstraZeneca
$66.81 /

+0.14 (+0.21%)

MRK Merck
$90.60 /

-0.39 (-0.43%)

08/14/22 SVB Securities
Seagen price target lowered to $152 from $159 at SVB Securities
08/05/22 Truist
Global Blood could complement any oncology franchise, says Truist
07/29/22 Barclays
Merck price target raised to $101 from $97 at Barclays
07/27/22 H.C. Wainwright
Seagen price target raised to $200 from $170 at H.C. Wainwright
AZN AstraZeneca
$66.81 /

+0.14 (+0.21%)

08/05/22 Morgan Stanley
AstraZeneca price target raised to 12,000 GBp from 11,500 GBp at Morgan Stanley
08/04/22 Barclays
AstraZeneca price target lowered to 12,000 GBp from 12,500 GBp at Barclays
08/01/22 JPMorgan
AstraZeneca price target raised to 12,500 GBp from 12,000 GBp at JPMorgan
08/01/22 Deutsche Bank
AstraZeneca price target raised to 12,000 GBp from 11,500 GBp at Deutsche Bank
MRK Merck
$90.60 /

-0.39 (-0.43%)

AZN AstraZeneca
$66.81 /

+0.14 (+0.21%)

MRK Merck
$90.60 /

-0.39 (-0.43%)

AZN AstraZeneca
$66.81 /

+0.14 (+0.21%)

MRK Merck
$90.60 /

-0.39 (-0.43%)

AZN AstraZeneca
$66.81 /

+0.14 (+0.21%)

MRK Merck
$90.60 /

-0.39 (-0.43%)

AZN AstraZeneca
$66.81 /

+0.14 (+0.21%)

Hot Stocks
Genentech announces FDA acceptance of Polivy combination sBLA » 05:24
08/16/22
08/16
05:24
08/16/22
05:24
RHHBY

Roche

$42.28 /

+0.28 (+0.67%)

Genentech, a member of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RHHBY Roche
$42.28 /

+0.28 (+0.67%)

RHHBY Roche
$42.28 /

+0.28 (+0.67%)

08/04/22 Wedbush
Arcus Biosciences price target lowered to $36 from $42 at Wedbush
07/25/22 JPMorgan
Roche price target lowered to CHF 300 from CHF 370 at JPMorgan
07/22/22 Deutsche Bank
Roche price target lowered to CHF 325 from CHF 350 at Deutsche Bank
07/20/22 Piper Sandler
Piper adjusts Ionis' Spinraza royalties estimate following Biogen report
RHHBY Roche
$42.28 /

+0.28 (+0.67%)

RHHBY Roche
$42.28 /

+0.28 (+0.67%)

RHHBY Roche
$42.28 /

+0.28 (+0.67%)

Hot Stocks
AstraZeneca's Lynparza combination granted Priority Review in U.S. » 05:20
08/16/22
08/16
05:20
08/16/22
05:20
AZN

AstraZeneca

$66.81 /

+0.14 (+0.21%)

, MRK

Merck

$90.60 /

-0.39 (-0.43%)

AstraZeneca's…

AstraZeneca's supplemental New Drug Application, or sNDA, for Lynparza in combination with abiraterone and prednisone or prednisolone has been accepted and granted Priority Review in the U.S. for the treatment of adult patients with metastatic castration-resistant prostate cancer, or mCRPC, the company announced. Lynparza is being jointly developed and commercialised by AstraZeneca (AZN) and Merck (MRK).

ShowHide Related Items >><<
MRK Merck
$90.60 /

-0.39 (-0.43%)

AZN AstraZeneca
$66.81 /

+0.14 (+0.21%)

AZN AstraZeneca
$66.81 /

+0.14 (+0.21%)

08/05/22 Morgan Stanley
AstraZeneca price target raised to 12,000 GBp from 11,500 GBp at Morgan Stanley
08/04/22 Barclays
AstraZeneca price target lowered to 12,000 GBp from 12,500 GBp at Barclays
08/01/22 JPMorgan
AstraZeneca price target raised to 12,500 GBp from 12,000 GBp at JPMorgan
08/01/22 Deutsche Bank
AstraZeneca price target raised to 12,000 GBp from 11,500 GBp at Deutsche Bank
MRK Merck
$90.60 /

-0.39 (-0.43%)

08/14/22 SVB Securities
Seagen price target lowered to $152 from $159 at SVB Securities
08/05/22 Truist
Global Blood could complement any oncology franchise, says Truist
07/29/22 Barclays
Merck price target raised to $101 from $97 at Barclays
07/27/22 H.C. Wainwright
Seagen price target raised to $200 from $170 at H.C. Wainwright
MRK Merck
$90.60 /

-0.39 (-0.43%)

AZN AstraZeneca
$66.81 /

+0.14 (+0.21%)

MRK Merck
$90.60 /

-0.39 (-0.43%)

AZN AstraZeneca
$66.81 /

+0.14 (+0.21%)

MRK Merck
$90.60 /

-0.39 (-0.43%)

AZN AstraZeneca
$66.81 /

+0.14 (+0.21%)

MRK Merck
$90.60 /

-0.39 (-0.43%)

AZN AstraZeneca
$66.81 /

+0.14 (+0.21%)

Hot Stocks
Roche says FDA accepts sBLA for Polivy combination » 05:15
08/16/22
08/16
05:15
08/16/22
05:15
RHHBY

Roche

$42.28 /

+0.28 (+0.67%)

Roche announced that the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RHHBY Roche
$42.28 /

+0.28 (+0.67%)

RHHBY Roche
$42.28 /

+0.28 (+0.67%)

08/04/22 Wedbush
Arcus Biosciences price target lowered to $36 from $42 at Wedbush
07/25/22 JPMorgan
Roche price target lowered to CHF 300 from CHF 370 at JPMorgan
07/22/22 Deutsche Bank
Roche price target lowered to CHF 325 from CHF 350 at Deutsche Bank
07/20/22 Piper Sandler
Piper adjusts Ionis' Spinraza royalties estimate following Biogen report
RHHBY Roche
$42.28 /

+0.28 (+0.67%)

RHHBY Roche
$42.28 /

+0.28 (+0.67%)

RHHBY Roche
$42.28 /

+0.28 (+0.67%)

Yesterday
Hot Stocks
Genentech gets FDA orphan designation for treatment of uveitic macular edema » 14:56
08/15/22
08/15
14:56
08/15/22
14:56
RHHBY

Roche

$42.00 /

+0.96 (+2.34%)

Genentech, a member of…

Genentech, a member of the Roche Group, received orphan designation from the FDA for a treatment of uveitic macular edema, according to a post to the agency's website. Reference Link

ShowHide Related Items >><<
RHHBY Roche
$42.00 /

+0.96 (+2.34%)

RHHBY Roche
$42.00 /

+0.96 (+2.34%)

08/04/22 Wedbush
Arcus Biosciences price target lowered to $36 from $42 at Wedbush
07/25/22 JPMorgan
Roche price target lowered to CHF 300 from CHF 370 at JPMorgan
07/22/22 Deutsche Bank
Roche price target lowered to CHF 325 from CHF 350 at Deutsche Bank
07/20/22 Piper Sandler
Piper adjusts Ionis' Spinraza royalties estimate following Biogen report
RHHBY Roche
$42.00 /

+0.96 (+2.34%)

RHHBY Roche
$42.00 /

+0.96 (+2.34%)

RHHBY Roche
$42.00 /

+0.96 (+2.34%)

Hot Stocks
Novartis' treatment of Malaria granted FDA orphan designation » 11:56
08/15/22
08/15
11:56
08/15/22
11:56
NVS

Novartis

$85.05 /

-0.63 (-0.74%)

Novartis…

Novartis Pharmaceuticals' ganaplacide and lumefantrine fixed-dose combination was granted FDA orphan designation as a treatment of malaria, according to a post to the agency's website. Reference Link

ShowHide Related Items >><<
NVS Novartis
$85.05 /

-0.63 (-0.74%)

NVS Novartis
$85.05 /

-0.63 (-0.74%)

08/05/22 Truist
Global Blood could complement any oncology franchise, says Truist
08/04/22 Truist
Truist sees Novartis, Vertex as logical suitors for Global Blood
07/20/22 JPMorgan
Novartis price target raised to CHF 81 from CHF 80 at JPMorgan
07/20/22 Piper Sandler
Piper adjusts Ionis' Spinraza royalties estimate following Biogen report
NVS Novartis
$85.05 /

-0.63 (-0.74%)

NVS Novartis
$85.05 /

-0.63 (-0.74%)

NVS Novartis
$85.05 /

-0.63 (-0.74%)

NVS Novartis
$85.05 /

-0.63 (-0.74%)

Initiation
Kymera Therapeutics initiated with a Buy at Jefferies » 08:00
08/15/22
08/15
08:00
08/15/22
08:00
KYMR

Kymera Therapeutics

$33.70 /

+1.135 (+3.49%)

, SNY

Sanofi

$44.39 /

+0.87 (+2.00%)

Jefferies analyst Kelly…

Jefferies analyst Kelly Shi initiated coverage of Kymera Therapeutics with a Buy rating and $40 price target. Kymera's Pegasus platform could match disease-causing proteins with appropriate E3 ligases in the autoimmune and oncology space, noted Shi. Sanofi (SNY) partnered lead asset KT-474 for autoimmune diseases has first-in-patient data due in Q4 that will significantly derisk the asset and trigger Sanofi to start Phase 2 study, said Shi, who adds that she thinks Kymera's "unique TPD platform ensures long-term success."

ShowHide Related Items >><<
SNY Sanofi
$44.39 /

+0.87 (+2.00%)

KYMR Kymera Therapeutics
$33.70 /

+1.135 (+3.49%)

KYMR Kymera Therapeutics
$33.70 /

+1.135 (+3.49%)

08/03/22 Goldman Sachs
Kymera Therapeutics initiated with a Buy at Goldman Sachs
07/20/22 SVB Securities
Kymera Therapeutics initiated with a Market Perform at SVB Securities
06/01/22 Wells Fargo
Kymera Therapeutics price target lowered to $35 from $62 at Wells Fargo
05/23/22 Piper Sandler
Kymera Therapeutics price target lowered to $43 from $91 at Piper Sandler
SNY Sanofi
$44.39 /

+0.87 (+2.00%)

08/12/22 Deutsche Bank
Deutsche Bank raises Sanofi to Hold, calls Zantac 'knee-jerk' reaction overdone
08/12/22 JPMorgan
Sanofi may not be liable for any Zantac litigation damages, says JPMorgan
08/12/22 Deutsche Bank
Sanofi upgraded to Hold from Sell at Deutsche Bank
08/11/22 JPMorgan
Perrigo, Pfizer appear to have manageable Zantac exposure, says JPMorgan
SNY Sanofi
$44.39 /

+0.87 (+2.00%)

KYMR Kymera Therapeutics
$33.70 /

+1.135 (+3.49%)

SNY Sanofi
$44.39 /

+0.87 (+2.00%)

SNY Sanofi
$44.39 /

+0.87 (+2.00%)

KYMR Kymera Therapeutics
$33.70 /

+1.135 (+3.49%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.